13
results
for author:"Schneider D.J."
in Literature Citations
| Augmentation of megakaryocyte expression of FcgammaRIIa by interferon gamma. Schneider D.J., Taatjes-Sommer H.S. Arterioscler. Thromb. Vasc. Biol. 29:1138-1143(2009) · Mapped (16) |
| Association between increased platelet P-selectin expression and obesity in patients with type 2 diabetes: a BARI 2D (Bypass Angioplasty Revascularization Investigation 2 Diabetes) substudy. Schneider D.J., Hardison R.M., Lopes N., Sobel B.E., Brooks M.M. Diabetes Care 32:944-949(2009) · Mapped (12) |
| A profibrotic effect of plasminogen activator inhibitor type-1 (PAI-1) in the heart. Zaman A.K., French C.J., Schneider D.J., Sobel B.E. Exp. Biol. Med. (Maywood) 234:246-254(2009) · Mapped (2) |
| Deleterious effects of lack of cardiac PAI-1 after coronary occlusion in mice and their pathophysiologic determinants. Zaman A.K., Fujii S., Schneider D.J., Taatjes D.J., Lijnen H.R., Sobel B.E. Histochem. Cell Biol. 128:135-145(2007) · Mapped (2) |
| Osteoprotegerin is not associated with angiographic coronary calcification. Gogo P.B. Jr., Schneider D.J., Terrien E.F., Sobel B.E., Dauerman H.L. J. Thromb. Thrombolysis 22:177-183(2006) · Mapped (1) |
| Insulin resistance increases PAI-1 in the heart. Sobel B.E., Schneider D.J., Lee Y.H., Pratley R.E. Biochem. Biophys. Res. Commun. 346:102-107(2006) · Mapped (14) |
| Increased expression of platelet P-selectin and formation of platelet-leukocyte aggregates in blood from patients treated with unfractionated heparin plus eptifibatide compared with bivalirudin. Keating F.K., Dauerman H.L., Whitaker D.A., Sobel B.E., Schneider D.J. Thromb. Res. 118:361-369(2006) · Mapped (12) |
| Complete genome sequence of the plant commensal Pseudomonas fluorescens Pf-5. Paulsen I.T., Press C.M., Ravel J., Kobayashi D.Y., Myers G.S.A., Mavrodi D.V., DeBoy R.T., Seshadri R., Ren Q., Madupu R. et al. Nat. Biotechnol. 23:873-878(2005) · UniProtKB (6,137) |
| Attenuation of neointimal vascular smooth muscle cellularity in atheroma by plasminogen activator inhibitor type 1 (PAI-1). Schneider D.J., Hayes M., Wadsworth M., Taatjes H., Rincon M., Taatjes D.J., Sobel B.E. J. Histochem. Cytochem. 52:1091-1099(2004) · Mapped (9) |
| Effects of insulin sensitizers on plaque vulnerability associated with elevated lipid content in atheroma in ApoE-knockout mice. Cefalu W.T., Wang Z.Q., Schneider D.J., Absher P.M., Baldor L.C., Taatjes D.J., Sobel B.E. Acta Diabetol 41:25-31(2004) · Mapped (9) |
| The complete genome sequence of the Arabidopsis and tomato pathogen Pseudomonas syringae pv. tomato DC3000. Buell C.R., Joardar V., Lindeberg M., Selengut J., Paulsen I.T., Gwinn M.L., Dodson R.J., DeBoy R.T., Durkin A.S., Kolonay J.F. et al. Proc. Natl. Acad. Sci. U.S.A. 100:10181-10186(2003) · UniProtKB (5,425) |
| Genomewide identification of proteins secreted by the Hrp type III protein secretion system of Pseudomonas syringae pv. tomato DC3000. Petnicki-Ocwieja T., Schneider D.J., Tam V.C., Chancey S.T., Shan L., Jamir Y., Schechter L.M., Janes M.D., Buell C.R., Tang X. et al. Proc. Natl. Acad. Sci. U.S.A. 99:7652-7657(2002) · UniProtKB (7) |
| Genomewide identification of Pseudomonas syringae pv. tomato DC3000 promoters controlled by the HrpL alternative sigma factor. Fouts D.E., Abramovitch R.B., Alfano J.R., Baldo A.M., Buell C.R., Cartinhour S., Chatterjee A.K., D'Ascenzo M., Gwinn M.L., Lazarowitz S.G. et al. Proc. Natl. Acad. Sci. U.S.A. 99:2275-2280(2002) · UniProtKB (1) |
